Late Breaking Abstract - Real-world effectiveness of remdesivir for hospitalized patients with COVID-19: systematic review and meta-analysis
L. Barnieh (New York, United States), R. Gottlieb (Dallas, United States), J. Malin (Cologne, Germany), R. Paredes (Badalona, Spain), R. Beckerman (New York, United States), R. Gupta (Uxbridge, United Kingdom), J. Jarrett (Uxbridge, United Kingdom), S. Jeyakumar (New York, United States), N. Smith (New York, United States), A. Texeiro-Pinto (Sydney, Australia)
Source: International Congress 2022 – Pneumonia
Session: Pneumonia
Session type: Thematic Poster
Number: 4037
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Barnieh (New York, United States), R. Gottlieb (Dallas, United States), J. Malin (Cologne, Germany), R. Paredes (Badalona, Spain), R. Beckerman (New York, United States), R. Gupta (Uxbridge, United Kingdom), J. Jarrett (Uxbridge, United Kingdom), S. Jeyakumar (New York, United States), N. Smith (New York, United States), A. Texeiro-Pinto (Sydney, Australia). Late Breaking Abstract - Real-world effectiveness of remdesivir for hospitalized patients with COVID-19: systematic review and meta-analysis. 4037
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|